Basic and Applied Research

Total Page:16

File Type:pdf, Size:1020Kb

Basic and Applied Research A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Gersbach, Hans; Sorger, Gerhard; Amon, Christian Working Paper Hierarchical Growth: Basic and Applied Research Economics Working Paper Series, No. 09/118 Provided in Cooperation with: ETH Zurich, CER-ETH – Center of Economic Research Suggested Citation: Gersbach, Hans; Sorger, Gerhard; Amon, Christian (2009) : Hierarchical Growth: Basic and Applied Research, Economics Working Paper Series, No. 09/118, ETH Zurich, CER-ETH - Center of Economic Research, Zurich, http://dx.doi.org/10.3929/ethz-a-005888472 This Version is available at: http://hdl.handle.net/10419/171561 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu CER-ETH – Center of Economic Research at ETH Zurich Hierarchical Growth: Basic and Applied Research Hans Gersbach, Gerhard Sorger and Christian Amon Working Paper 09/118 August 2009 Economics Working Paper Series Hierarchical Growth: Basic and Applied Research∗ Hans Gersbach Gerhard Sorger CER-ETH Center of Economic Research Department of Economics at ETH Zurich and CEPR University of Vienna 8032 Zurich, Switzerland 1010 Vienna, Austria [email protected] [email protected] Christian Amon CER-ETH Center of Economic Research at ETH Zurich 8032 Zurich, Switzerland [email protected] This Version: July 2009 Abstract We develop a model that incorporates salient features of growth in modern economies. We combine the expanding-variety growth model through horizontal innovations with a hierarchy of basic and applied research. The former extends the knowledge base, while the latter commercializes it. Two-way spillovers reinforce the productivity of research in each sector. We establish the existence of balanced growth paths. Along such paths the stock of ideas and the stock of commercialized blueprints for intermediate goods grow with the same rate. Basic research is a necessary and sufficient condition for economic growth. We show that there can be two different facets of growth in the economy. First, growth may be entirely shaped by investments in basic research if applied research operates at the knowledge frontier. Second, long-run growth may be shaped by both basic and applied research and growth can be further stimulated by research subsidies. We illustrate different types of growth processes by examples and polar cases when only upward or downward spillovers between basic and applied research are present. Keywords: Basic research, applied research, knowledge base, commercialization, hi- erarchical economic growth JEL Classification: H41, O31, O41 ∗We would like to thank Maik Schneider, Ralph Winkler and seminar participants at ETH Zurich for valu- able comments and suggestions. 1 “It is likely that the bulk of the economic benefits of university research come from inven- tions in the private sector that build upon the scientific and engineering base created by uni- versity research, rather than from commercial inventions generated directly by universities.” [Henderson et al. (1998), p. 126] 1 Introduction The innovation processes in both industrialized and industrializing countries are typically characterized by a hierarchy of basic and applied research. Basic research is mainly publicly funded and extends the knowledge base of an economy by generating novel ideas, theories, and prototypes that are usually of no immediate commercial use. Applied research, on the other hand, is primarily carried out by private firms, which commercialize the output of basic research by transforming it into blueprints for new products. Moreover, basic and applied research reinforce each other throughout the entire process of knowledge base extension and commercialization. For example, applied research benefits from basic research because the latter provides knowledge and methods that support the problem-solving processes at research-active private firms, whereas basic research benefits from applied research as the latter identifies unresolved problems and discovers new challenges for basic research. That is, the innovation process is characterized by two-way spillovers between basic and applied research. This paper develops an endogenous growth model that captures the above hierarchy and in- terdependency of the innovation process. We analyze a closed economy with a final and an intermediate goods sector, a basic and an applied research sector, a continuum of infinitely lived households, and a government. Technological progress is the result of a hierarchical innovation process modelled along the lines sketched above: basic research is financed by the government and extends the knowledge base of the economy, whereas applied research is carried out by private firms that transform basic knowledge into blueprints for new inter- mediate goods. In addition, two-way spillovers between basic and applied research reinforce the productivity in each research sector. In this setup, the government can influence growth and welfare of the economy by choosing the size of the basic research sector and by granting subsidies to researchers. Both of these government activities are financed by taxes on labor income. Our model stands in the tradition of the expanding-variety framework of growth through horizontal innovations initiated by Romer (1990).1 The crucial features of our model are the hierarchy in the innovation process and the two-way spillovers between basic and applied research as described above. While Romer and others effectively assumed an exogenous, 1See Gancia and Zilibotti (2005) for a recent review of the development, extensions, and applications of the expanding-variety framework. 2 non-exhaustible pool of knowledge available that can be exploited by applied researchers to invent blueprints for new intermediate goods, we endogenize this knowledge pool as the output of a basic research sector. In other words, we assume that the productivity of applied research is constrained by the “knowledge frontier” of the economy which, in turn, can only be pushed outwards by basic research. In particular, growth is about to cease in the long-run unless the knowledge base of the economy is permanently expanded by basic research. We establish the existence of balanced growth paths. Along such paths the stock of ideas and the stock of commercialized blueprints for intermediate goods grow with the same rate. Ba- sic research is a necessary and sufficient condition for economic growth. We show that there can be two different facets of growth in the economy. First, growth may be entirely shaped by investments in basic research if applied research operates at the knowledge frontier. Sec- ond, long-run growth may be shaped by both basic and applied research and growth can be further stimulated by research subsidies. We illustrate different types of growth processes by examples and polar cases when only upward or downward spillovers are present. In the former case, a higher share of labor employed in basic research translates into higher growth rates and applied research operates at the knowledge frontier. In the latter case, growth is declining if basic research exceeds a certain threshold and ceases entirely if basic research is increased further as undertaking applied research becomes unprofitable. So far, only few attempts have been made to analyze the impact of publicly-funded basic research in a dynamic setup. Among the first were Shell’s (1966, 1967) contributions, which highlight the necessity of allocating economic resources to the process of invention. Thereby, Shell’s concept of technical knowledge, which he treats as a public good financed solely by means of output taxes, corresponds closely to our notion of basic research. Similarly, Gross- man and Helpman (1991) address the positive impact on growth of basic research financed by means of income taxes vis-a-vis` the negative effect caused by the associated tax distor- tions. In order to evaluate the impact of various research policies, Morales (2004) considers an endogenous growth model of vertical innovation incorporating both basic and applied research performed by both private firms and the government. While these and other contri- butions shed light on the positive impact of publicly-funded basic research on growth, they do neither consider the hierarchy of basic and applied research nor the two-way spillovers between the two types of research in the process of innovation. Our formulation of two-way spillovers between basic and applied research follows
Recommended publications
  • Ethical Principles in Ethical Principles in Scientific Research Scientific Research and Publications
    Hacettepe University Institute of Oncology Library ETHICAL PRINCIPLES IN SCIENTIFIC LectureRESEARCH author AND PUBLICATIONSOnlineby © Emin Kansu,M.D.,FACP ESCMID ekansu@ada. net. tr Library Lecture author Onlineby © ESCMID HACETTEPE UNIVERSITY MEDICAL CENTER Library Lecture author Onlineby © ESCMID INSTITUTE OF ONCOLOGY - HACETTEPE UNIVERSITY Ankara PRESENTATION • UNIVERSITY and RESEARCHLibrary • ETHICS – DEFINITION • RESEARCH ETHICS • PUBLICATIONLecture ETHICS • SCIENTIFIC MISCONDUCTauthor • SCIENTIFIC FRAUD AND TYPES Onlineby • HOW TO PREVENT© UNETHICAL ISSUES • WHAT TO DO FOR SCIENTIFIC ESCMIDMISCONDUCTS Library Lecture author Onlineby © ESCMID IMPACT OF TURKISH SCIENTISTS 85 % University – Based 1.78% 0.2 % 19. 300 18th ‘ACADEMIA’ UNIVERSITY Library AN INSTITUTION PRODUCING and DISSEMINATING SCIENCE Lecture BASIC FUNCTIONS author Online-- EDUCATIONby © -- RESEARCH ESCMID - SERVICESERVICE UNIVERSITY Library • HAS TO BE OBJECTIVE • HAS TO BE HONESTLecture AND ETHICAL • HAS TO PERFORM THEauthor “STATE-OF-THE ART” • HAS TO PLAYOnline THEby “ROLE MODEL” , TO BE GENUINE AND ©DISCOVER THE “NEW” • HAS TO COMMUNICATE FREELY AND HONESTLY WITH ALL THE PARTIES INVOLVED IN ESCMIDPUBLIC WHY WE DO RESEARCH ? Library PRIMARY AIM - ORIGINAL CONTRIBUTIONS TO SCIENCE Lecture SECONDARY AIM author - TOOnline PRODUCEby A PAPER - ACADEMIC© PROMOTION - TO OBTAIN AN OUTSIDE SUPPORT ESCMID SCIENTIFIC RESEARCH Library A Practice aimed to contribute to knowledge or theoryLecture , performed in disciplined methodologyauthor and Onlineby systematic approach©
    [Show full text]
  • Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA
    GENE SILENCING BY DOUBLE STRANDED RNA Nobel Lecture, December 8, 2006 by Andrew Z. Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA. I would like to thank the Nobel Assembly of the Karolinska Institutet for the opportunity to describe some recent work on RNA-triggered gene silencing. First a few disclaimers, however. Telling the full story of gene silencing would be a mammoth enterprise that would take me many years to write and would take you well into the night to read. So we’ll need to abbreviate the story more than a little. Second (and as you will see) we are only in the dawn of our knowledge; so consider the following to be primer... the best we could do as of December 8th, 2006. And third, please understand that the story that I am telling represents the work of several generations of biologists, chemists, and many shades in between. I’m pleased and proud that work from my labo- ratory has contributed to the field, and that this has led to my being chosen as one of the messengers to relay the story in this forum. At the same time, I hope that there will be no confusion of equating our modest contributions with those of the much grander RNAi enterprise. DOUBLE STRANDED RNA AS A BIOLOGICAL ALARM SIGNAL These disclaimers in hand, the story can now start with a biography of the first main character. Double stranded RNA is probably as old (or almost as old) as life on earth.
    [Show full text]
  • ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM
    2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region
    [Show full text]
  • Jewish Nobel Prize Laureates
    Jewish Nobel Prize Laureates In December 1902, the first Nobel Prize was awarded in Stockholm to Wilhelm Roentgen, the discoverer of X-rays. Alfred Nobel (1833-96), a Swedish industrialist and inventor of dynamite, had bequeathed a $9 million endowment to fund significant cash prizes ($40,000 in 1901, about $1 million today) to those individuals who had made the most important contributions in five domains (Physics, Chemistry, Physiology or Medicine, Literature and Peace); the sixth, in "Economic Sciences," was added in 1969. Nobel could hardly have imagined the almost mythic status that would accrue to the laureates. From the start "The Prize" became one of the most sought-after awards in the world, and eventually the yardstick against which other prizes and recognition were to be measured. Certainly the roster of Nobel laureates includes many of the most famous names of the 20th century: Marie Curie, Albert Einstein, Mother Teresa, Winston Churchill, Albert Camus, Boris Pasternak, Albert Schweitzer, the Dalai Lama and many others. Nobel Prizes have been awarded to approximately 850 laureates of whom at least 177 of them are/were Jewish although Jews comprise less than 0.2% of the world's population. In the 20th century, Jews, more than any other minority, ethnic or cultural, have been recipients of the Nobel Prize. How to account for Jewish proficiency at winning Nobel’s? It's certainly not because Jews do the judging. All but one of the Nobel’s are awarded by Swedish institutions (the Peace Prize by Norway). The standard answer is that the premium placed on study and scholarship in Jewish culture inclines Jews toward more education, which in turn makes a higher proportion of them "Nobel-eligible" than in the larger population.
    [Show full text]
  • Close to the Edge: Co-Authorship Proximity of Nobel Laureates in Physiology Or Medicine, 1991 - 2010, to Cross-Disciplinary Brokers
    Close to the edge: Co-authorship proximity of Nobel laureates in Physiology or Medicine, 1991 - 2010, to cross-disciplinary brokers Chris Fields 528 Zinnia Court Sonoma, CA 95476 USA fi[email protected] January 2, 2015 Abstract Between 1991 and 2010, 45 scientists were honored with Nobel prizes in Physiology or Medicine. It is shown that these 45 Nobel laureates are separated, on average, by at most 2.8 co-authorship steps from at least one cross-disciplinary broker, defined as a researcher who has published co-authored papers both in some biomedical discipline and in some non-biomedical discipline. If Nobel laureates in Physiology or Medicine and their immediate collaborators can be regarded as forming the intuitive “center” of the biomedical sciences, then at least for this 20-year sample of Nobel laureates, the center of the biomedical sciences within the co-authorship graph of all of the sciences is closer to the edges of multiple non-biomedical disciplines than typical biomedical researchers are to each other. Keywords: Biomedicine; Co-authorship graphs; Cross-disciplinary brokerage; Graph cen- trality; Preferential attachment Running head: Proximity of Nobel laureates to cross-disciplinary brokers 1 1 Introduction It is intuitively tempting to visualize scientific disciplines as spheres, with highly produc- tive, well-funded intellectual and political leaders such as Nobel laureates occupying their centers and less productive, less well-funded researchers being increasingly peripheral. As preferential attachment mechanisms as well as the economics of employment tend to give the well-known and well-funded more collaborators than the less well-known and less well- funded (e.g.
    [Show full text]
  • The Nobel Prize in Physiology Or Medicine 2006
    The Nobel Prize in Physiology or Medicine 2006 Craig C. Mello, PhD The Magazine of The University of Massachusetts Medical School fall/winter 2006, Vol. 29 No. 1 L., the plural of life The name of this magazine encompasses the lives of those who make up the University of Massachusetts Medical School community, for which it is published. They are students, faculty, staff, alumni, volunteers, benefactors and others who aspire to help this campus achieve national distinction in education, research and public service. As you read about this dynamic community, you’ll frequently come across references to partners and programs of UMass Medical School (UMMS), the Commonwealth of Massachusetts’ only public medical school, educating physicians, scientists and advanced practice nurses to heal, discover, teach and care, compassionately. Commonwealth Medicine UMass Medical School’s innovative public service initiative that assists state agencies to enhance the value and quality of expenditures and improve access and delivery of care for at-risk and uninsured populations. The Research Enterprise UMass Medical School’s world-class investigators, who make discoveries in basic science and clinical research and attract over $175 million in funding annually. UMass Memorial Foundation The charitable entity that supports the academic and research enterprises of UMass Medical School and the clinical initiatives of UMass Memorial Health Care by forming vital partnerships between contributors and health care professionals, educators and researchers. www.umassmed.edu/foundation UMass Memorial Health Care The clinical partner of UMass Medical School and the Central New England region’s top health care provider and employer. www.umassmemorial.org Contents News and Notes 4 Features 7 Grants and Research 21 Alumni Report 23 The Last Word 28 The Nobel Prize Comes to UMass Medical School 2 Professor Craig Mello, PhD, and his collaborator Andrew Fire, PhD, of Stanford University School of Medicine, are co-recipients of the 2006 award in medicine.
    [Show full text]
  • Celebrating 40 Years of Rita Allen Foundation Scholars 1 PEOPLE Rita Allen Foundation Scholars: 1976–2016
    TABLE OF CONTENTS ORIGINS From the President . 4 Exploration and Discovery: 40 Years of the Rita Allen Foundation Scholars Program . .5 Unexpected Connections: A Conversation with Arnold Levine . .6 SCIENTIFIC ADVISORY COMMITTEE Pioneering Pain Researcher Invests in Next Generation of Scholars: A Conversation with Kathleen Foley (1978) . .10 Douglas Fearon: Attacking Disease with Insights . .12 Jeffrey Macklis (1991): Making and Mending the Brain’s Machinery . .15 Gregory Hannon (2000): Tools for Tough Questions . .18 Joan Steitz, Carl Nathan (1984) and Charles Gilbert (1986) . 21 KEYNOTE SPEAKERS Robert Weinberg (1976): The Genesis of Cancer Genetics . .26 Thomas Jessell (1984): Linking Molecules to Perception and Motion . 29 Titia de Lange (1995): The Complex Puzzle of Chromosome Ends . .32 Andrew Fire (1989): The Resonance of Gene Silencing . 35 Yigong Shi (1999): Illuminating the Cell’s Critical Systems . .37 SCHOLAR PROFILES Tom Maniatis (1978): Mastering Methods and Exploring Molecular Mechanisms . 40 Bruce Stillman (1983): The Foundations of DNA Replication . .43 Luis Villarreal (1983): A Life in Viruses . .46 Gilbert Chu (1988): DNA Dreamer . .49 Jon Levine (1988): A Passion for Deciphering Pain . 52 Susan Dymecki (1999): Serotonin Circuit Master . 55 Hao Wu (2002): The Cellular Dimensions of Immunity . .58 Ajay Chawla (2003): Beyond Immunity . 61 Christopher Lima (2003): Structure Meets Function . 64 Laura Johnston (2004): How Life Shapes Up . .67 Senthil Muthuswamy (2004): Tackling Cancer in Three Dimensions . .70 David Sabatini (2004): Fueling Cell Growth . .73 David Tuveson (2004): Decoding a Cryptic Cancer . 76 Hilary Coller (2005): When Cells Sleep . .79 Diana Bautista (2010): An Itch for Knowledge . .82 David Prober (2010): Sleeping Like the Fishes .
    [Show full text]
  • Contributions of Civilizations to International Prizes
    CONTRIBUTIONS OF CIVILIZATIONS TO INTERNATIONAL PRIZES Split of Nobel prizes and Fields medals by civilization : PHYSICS .......................................................................................................................................................................... 1 CHEMISTRY .................................................................................................................................................................... 2 PHYSIOLOGY / MEDECINE .............................................................................................................................................. 3 LITERATURE ................................................................................................................................................................... 4 ECONOMY ...................................................................................................................................................................... 5 MATHEMATICS (Fields) .................................................................................................................................................. 5 PHYSICS Occidental / Judeo-christian (198) Alekseï Abrikossov / Zhores Alferov / Hannes Alfvén / Eric Allin Cornell / Luis Walter Alvarez / Carl David Anderson / Philip Warren Anderson / EdWard Victor Appleton / ArthUr Ashkin / John Bardeen / Barry C. Barish / Nikolay Basov / Henri BecqUerel / Johannes Georg Bednorz / Hans Bethe / Gerd Binnig / Patrick Blackett / Felix Bloch / Nicolaas Bloembergen
    [Show full text]
  • Ramakrishna Mission Vivekananda Educational and Research Institute
    Ramakrishna Mission Vivekananda Educational and Research Institute (Declared by Govt of India under Section 3 of UGC Act, 1956) School of Agriculture and Rural Development Faculty Centre for INTEGRATED RURAL DEVELOPMENT & MANAGEMENT (IRDM) Ramakrishna Mission Ashrama, Narendrapur, Kolkata: 700 103 Course: M.Sc. in Agricultural Biotechnology (AgBT) Entrance Examination 2017 Date: 10. 06. 2017 Time: 1 hour Full Marks: 60 Important Instructions 1. Section-A is compulsory. 2. Answer any two of the five Groups (I, II, III, IV and V) under Section-B. 3. For answering Multiple Choice Questions in any group, underline the correct answer in the question paper itself. 4. Use extra sheet (to be provided) for Section-B in case of Group-I to V. Name of the Candidate : _________________________________________________ Registration No. : _________________________________________________ B. Sc. in : _________________________________________________ For Office Use Only Group Max. Marks Marks Obtained Section-A: Basics of General Sciences 20 Section-B: Subject Test (any two of the following groups) Group-I: Botany 40 Group-II: Zoology Group-III: Microbiology Group-IV: Biochemistry Group-V: Biotechnology TOTAL 60 Page 1 Section A: Basics in General Sciences Underline the correct answer. Each question carries 1 mark. There will be no negative marking for wrong answers. 1. ‘Central dogma of Biology’ was put forward by a) Watson b) Crick c) Temin d) Khorana 2. The enzyme required for transcription is a) Restriction enzymes b) DNA polymerase c) RNA polymerase d) RNAase 3. Which one is not a part of chlroplasts? a) thylakoid b) matrix c) stroma d) granum 4. Which one of the following is not a nitrogenous fertilizer? a) Muriate of Potash b) Potassium nitrate c) Ammonium nitate d) Urea 5.
    [Show full text]
  • List of Nobel Laureates 1
    List of Nobel laureates 1 List of Nobel laureates The Nobel Prizes (Swedish: Nobelpriset, Norwegian: Nobelprisen) are awarded annually by the Royal Swedish Academy of Sciences, the Swedish Academy, the Karolinska Institute, and the Norwegian Nobel Committee to individuals and organizations who make outstanding contributions in the fields of chemistry, physics, literature, peace, and physiology or medicine.[1] They were established by the 1895 will of Alfred Nobel, which dictates that the awards should be administered by the Nobel Foundation. Another prize, the Nobel Memorial Prize in Economic Sciences, was established in 1968 by the Sveriges Riksbank, the central bank of Sweden, for contributors to the field of economics.[2] Each prize is awarded by a separate committee; the Royal Swedish Academy of Sciences awards the Prizes in Physics, Chemistry, and Economics, the Karolinska Institute awards the Prize in Physiology or Medicine, and the Norwegian Nobel Committee awards the Prize in Peace.[3] Each recipient receives a medal, a diploma and a monetary award that has varied throughout the years.[2] In 1901, the recipients of the first Nobel Prizes were given 150,782 SEK, which is equal to 7,731,004 SEK in December 2007. In 2008, the winners were awarded a prize amount of 10,000,000 SEK.[4] The awards are presented in Stockholm in an annual ceremony on December 10, the anniversary of Nobel's death.[5] As of 2011, 826 individuals and 20 organizations have been awarded a Nobel Prize, including 69 winners of the Nobel Memorial Prize in Economic Sciences.[6] Four Nobel laureates were not permitted by their governments to accept the Nobel Prize.
    [Show full text]
  • Printwhatyoulike on ノーベル生理学・医学賞
    ノーベル生理学・医学賞 出典: フリー百科事典『ウィキペディア(Wikipedia)』 ノーベル賞 > ノーベル生理学・医学賞 ノーベル生理学・医学賞(ノーベルせいりがく・いがくしょう)はノーベル賞6部門のうちの1つ。「(動物)生理学及び医学の分野で 最も重要な発見を行なった」人に与えられる。選考はカロリンスカ研究所のノーベル賞委員会が行う。 歴代受賞者 [編集] 年度 受賞者名 国籍 受賞理由 エミール・アドルフ・フォン・ 血清療法の研究、特にジフテリアに対するものによって、 1901 ベーリング ドイツ帝国 医学の新しい分野を切り開き、生理学者の手に疾病や死 年 Emil Adolf von Behring に勝利しうる手段を提供したこと 1902 ロナルド・ロス マラリアの研究によってその感染経路を示し、疾病やそれ イギリス 年 Ronald Ross に対抗する手段に関する研究の基礎を築いたこと 1903 ニールス・フィンセン 疾病の治療法への寄与、特に尋常性狼瘡への光線治療法 デンマーク 年 Niels Ryberg Finsen によって、医学の新しい領域を開拓したこと 1904 イワン・パブロフ 消化生理の研究により、その性質に関する知見を転換し ロシア連邦 年 Ivan Petrovich Pavlov 拡張したこと 1905 ロベルト・コッホ ドイツ帝国 結核に関する研究と発見 年 Robert Koch カミッロ・ゴルジ イタリア王国 Camillo Golgi 1906 神経系の構造研究 年 サンティアゴ・ラモン・イ・カ ハール スペイン Santiago Ramon y Cajal シャルル・ルイ・アルフォンス・ 1907 ラヴラン フランス 疾病発生における原虫類の役割に関する研究 年 Charles Louis Alphonse Laveran パウル・エールリヒ ドイツ帝国 1908 Paul Ehrlich 免疫の研究 年 イリヤ・メチニコフ ロシア連邦 Ilya Ilyich Mechnikov 1909 エーミール・コッハー スイス 甲状腺の生理学、病理学および外科学的研究 年 Emil Theodor Kocher 1910 アルブレヒト・コッセル 核酸物質を含む、タンパク質に関する研究による細胞化学 ドイツ帝国 年 Albrecht Kossel の知見への寄与 1911 アルヴァル・グルストランド スウェーデン 眼の屈折機能に関する研究 年 Allvar Gullstrand 1912 アレクシス・カレル フランス 血管縫合および臓器の移植に関する研究 年 Alexis Carrel 1913 シャルル・ロベール・リシェ フランス アナフィラキシーの研究 年 Charles Robert Richet 1914 ローベルト・バーラーニ オーストリア=ハンガリー 内耳系の生理学および病理学に関する研究 年 Robert Bárány 帝国 1915 受賞者なし 年 1916 受賞者なし 年 1917 受賞者なし 年 1918 受賞者なし 年 1919 ジュール・ボルデ ベルギー 免疫に関する諸発見 年 Jules Bordet アウグスト・クローグ 1920 Schack August Steenberg デンマーク 毛細血管運動に関する調整機構の発見 年 Krogh 1921 受賞者なし 年 アーチボルド・ヒル イギリス 筋肉中の熱生成に関する発見 1922 Archibald Vivian Hill 年 オットー・マイヤーホフ ドイツ 筋肉における乳酸生成と酸素消費の固定的関連の発見 Otto Fritz Meyerhof
    [Show full text]
  • Global Peace Project-EN
    Statements Dr. Thomas Föhl Dr. Herbert Jost-Hof Prof. Niklas Luhmann “Based on the method of conducting ”Thus Lietdke‘s creative work reminds “The creativity formula is an evolutionary achievement. scientific research by means of art and of artists like Leonardo da Vinci, who used their creativity in Having been discovered and once it has been philosophy, lost since the renaissance, an interdisciplinary way in order Performed, she alone will do what she can. “ Liedtke is the first artist after almost 5 to eliminate the usual division between substance and spirit, centuries to once more achieve art and scientific cognition and artistic fantasy. “Dieter Liedtke unravels the conditions of research results of the highest quality.” Liedtke‘s works, like those by da Vinci, reveal his prophetic familiar theories. His ideas and his art-work properties, show that his findings are years ahead of those of require an observer, i.e. God, for whom time as “Briefly after their creation, his advanced findings scientific research. It‘s not yet clear the sum of all moments is present.“ were documented in his works of art, books and how such a thing is possible. exhibitions. New facts confirming Liedtke‘s findings, But there is decisive evidence that it is possible.“ “Dieter Liedtke unravels the conditions of independently of his art and studies, are regularly familiar theories. His ideas and his art-work discovered years after by prominent researchers in “Liedtke is a thinker and researcher whose partly intuitive, partly require an observer, i.e. God, for whom time as various areas of science.
    [Show full text]